Steroid hormones are generally thought to pass easily across a plasma membrane into a cell, interacting once inside with soluble nuclear receptors, but recent experiments have demonstrated the importance of membrane-bound receptors in mediating the activity and the metabolism of steroid hormones.
These discoveries were the origins of the classical model for steroid hormone action ( Figure 1a ). In this model, the hydrophobic steroid hormones are transported in the circulation largely bound to plasma carrier proteins. The bound hormones are biologically inactive. According to the 'free hormone hypothesis' (reviewed in [3] ), steroid hormones exert their effects after dissociating from the carrier proteins. It is thought that, because of their lipophilic nature, free steroid hormones enter target cells primarily by passive diffusion through the cell membrane. After gaining entry to the cell, steroid hormones act as ligands for nuclear receptors and alter gene transcription (reviewed in [4] ).
A cell-surface receptor for a steroid hormone
Passive diffusion of steroid hormones across cell membranes does not, however, adequately explain several observations regarding the cellular uptake of steroid hormones. Kinetic studies of steroid hormone metabolism, such as those for vitamin D, have suggested that the nonspecific diffusion of free hormones across cell membranes cannot fully account for their clearance rates from the serum [5] . Furthermore, some steroid target tissues express binding sites for carrier proteins (reviewed in [6] ), and certain human breast cancer cells can internalize testosterone/estradiol-binding protein by receptor-mediated endocytosis [7] . These findings have suggested that receptor-mediated uptake of steroid hormones, bound to their carrier proteins, may play a role in steroid metabolism, although the physiological significance of such pathways has been unclear.
A recent study by Willnow and colleagues [8] alters our view of steroid hormone metabolism by demonstrating both the existence and the biological importance of a receptormediated endocytosis pathway for a steroid-like hormone in its carrier-protein-bound state. These researchers studied 'knockout' mice lacking megalin, a membrane receptor that is a member of the low density lipoprotein (LDL) receptor family and is expressed on the apical surfaces of several epithelial cell types, including those in the choroid plexus and the proximal tubule of the kidney. Like several other members of the LDL receptor family, megalin has relatively broad ligand-binding specificity and mediates the cellular uptake of a number of macromolecules.
Although most megalin -/-mice die perinatally because of defective forebrain development [9] , approximately one in fifty survive to adulthood. It was these mice, which exhibit severe bone malformation and dramatically reduced bone density, that Nykjaer et al. [8] studied. Because megalin had previously been shown to be capable of taking up molecules injected into proximal renal tubules, and because electron microscopy of kidneys from megalin -/-mice demonstrated fewer endocytic organelles than normal, the researchers hypothesized that megalin -/-mice may be unable to resorb certain macromolecules from the urine.
To test this hypothesis, Nykjaer et al. [8] performed a simple but key experiment -they compared the urinary proteins of megalin -/-mice with those of wild-type mice by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. They found that several low-molecularweight proteins were present only in the urine of the megalin -/-mice. One of these proteins was identified as vitamin D-binding protein, the principal carrier protein for vitamin D in the serum. The investigators went on to show that urinary excretion of vitamin D-binding protein and 25-(OH) vitamin D 3 was markedly increased in megalin -/-mice, and there was an accompanying 80% reduction of plasma 25-(OH) vitamin D 3 . Moreover, similar changes could be induced in rats by infusing kidney tubules with receptor-associated protein, a protein that binds to megalin and other LDL-receptor family members and prevents them from binding ligands. studies demonstrate that a receptor-mediated endocytosis pathway not only exists for a steroid-like hormone but also plays a crucial role in the hormone's activity and metabolism (Figure 1b ).
Membrane receptors in steroid hormone action
Evidence is accumulating that cell-membrane receptors can not only take up steroid hormones through endocytosis, but also mediate steroid hormone action directly in some cases. Steroid hormones sometimes elicit extremely fast cellular responses (within seconds to minutes), which are too rapid to be attributed to induced RNA or protein synthesis. In the late 1960s, Szego et al. [10] showed that estrogen acutely raised cyclic AMP levels in rat uterus; several years later, Pietras et al. [11] identified specific binding sites for estrogen at the outer surfaces of isolated endometrial cells. Since then, steroid hormone action has been implicated in the opening and closing ion channels, the generation of second messengers, and the phosphorylation of transcription factors (reviewed in [12] ), all independent of any action at the genomic level.
How do steroid hormones act at the cell membrane? One way seems to involve direct binding of steroids to receptors of peptide hormones. Grazzini et al. [13] have recently elucidated the mechanism by which progesterone, a steroid hormone essential for maintaining mammalian pregnancy, can effect uterine quiescence without changing gene expression or protein synthesis. They found that progesterone directly inhibited the activity of oxytocin, a peptide capable of inducing uterine contractions, by binding to cell-surface oxytocin receptors. This action of progesterone reduced two functional consequences of oxytocin signalling: production of the second messenger inositol-1,4,5-triphosphate and an increase in intracellular calcium concentration. These results therefore illustrate another mechanism of steroid hormone action -the modulation of signalling through cellsurface receptors (Figure 1c) . In some instances, steroid hormones might also bind specifically to cell-surface steroid hormone receptors [14] .
Why are there multiple pathways of steroid action?
Why should steroid hormones interact with receptors both at the cell surface and in the nucleus? Szego [15] has suggested that the synthesis of macromolecules as a result of genomic actions of steroid hormones must be preceded by rapid changes in the cellular environment to 'prime' the cell and support such activity. These preparative changes may include altered ion influxes, import of amino acids and sugars, or phosphorylation of key enzymes, all of which could be triggered by interactions of steroid hormones with cell-surface receptors.
The interaction of steroid hormones with endocytic receptors could serve to target steroids to specific cell types in order to augment their effects or metabolism. In contrast to the classical model, in which steroid hormones diffuse into target tissues in a non-specific fashion, receptor-mediated endocytosis could serve to concentrate steroid hormones in particular cell types, thereby increasing hormonal activity at the target tissues without exposing the rest of the organism to equally high levels of the hormone. Alternatively, as shown for vitamin D and megalin, receptor-mediated endocytosis of the carrier protein-steroid hormone complex might target a hormone to a specific cell type that is important for its metabolism.
Perspectives
Recent advances have demonstrated the importance of membrane-bound receptors in mediating the activity and the metabolism of steroid hormones. These new discoveries raise a number of questions. Are the cases discovered above isolated findings, or are many steroid hormones capable of interacting with cell-surface receptors? If so, which steroids and receptors are involved, and what roles do these interactions play in their actions or metabolism? These advances may also have important medical implications. For example, these receptor-steroid interactions might provide new sites for therapeutic interventions: perhaps a compound that solely antagonizes the receptormediated uptake of bound steroid hormones would be more efficacious or cause fewer side effects than a nonselective steroid antagonist. Functional studies of specific receptors may provide answers to these questions.
